Biopharma Insights - page 16

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech sectors being no exception. It is …

Continue ›››

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, up to 90% of the on-the-market therapeutics are small molecules, …

Continue ›››

The Increasing Role of CROs in the Pharmaceutical Industry

(Last updated: July 2023) Pharmaceutical companies are increasingly outsourcing research activities to academic institutions, tech-driven companies, and private contract research organizations (CROs) as a strategy to stay competitive and flexible …

Continue ›››

How AI-Driven Multi-Omics is Reshaping Drug Discovery

The fusion of artificial intelligence (AI) with multi-omics - a comprehensive study encompassing genomics, transcriptomics, proteomics, metabolomics, and other related fields - is heralding an era of speedier, more efficient …

Continue ›››

VRG50635, a Drug Discovered Through Verge Genomics' AI-powered planform, Shows Promising Phase 1 Results for ALS Treatment

Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of VRG50635, an investigational drug for Amyotrophic Lateral Sclerosis (ALS). The …

Continue ›››

How to Discover a Preclinical Drug Candidate in Two Years

IgGenix Advances Therapeutic Approach to Peanut Allergies with IgG4 Monoclonal Antibodies

IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut allergies based on IgG4 monoclonal antibodies.

Continue ›››

Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey

Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and integration of open-source software and public cloud services. New research …

Continue ›››

The Rising Role of AI-enabled Digital Pathology in Drug Discovery

The field of pathology has experienced a major shift over the past few decades. This evolution began as early as the 1960s with the pioneering efforts in telepathology. However, the …

Continue ›››

Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities

Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial intelligence (AI) capabilities and data fabric connectivity to its clinical …

Continue ›››

Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery

Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently entered into a collaboration agreement. The partnership aims to leverage …

Continue ›››

CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access

Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving access to vaccines. In this context, the Coalition for Epidemic …

Continue ›››